Programmed death-ligand 1 expression in tumor cells and tumor-infiltrating lymphocytes are associated with depth of tumor invasion in penile cancer

被引:2
作者
Sangkhamanon, Sakkarn [1 ]
Kotano, Natcha [1 ]
Sirithanaphol, Wichien [2 ]
Rompsaithong, Ukrit [2 ]
Kiatsopit, Pakorn [2 ]
Sookprasert, Aumkhae [3 ]
Wirasorn, Kosin [3 ]
Twinprai, Prin [4 ]
Watcharenwong, Piyakarn [3 ]
Chindaprasirt, Jarin [3 ,5 ]
机构
[1] Khon Kaen Univ, Fac Med, Dept Pathol, Khon Kaen 40002, Thailand
[2] Khon Kaen Univ, Fac Med, Dept Surg, Div Urol Surg, Khon Kaen 40002, Thailand
[3] Khon Kaen Univ, Fac Med, Dept Internal Med, Div Med Oncol, Khon Kaen 40002, Thailand
[4] Khon Kaen Univ, Fac Med, Dept Radiol, Khon Kaen 40002, Thailand
[5] Khon Kaen Univ, Fac Med, Dept Internal Med, Div Med Oncol, 123 Mitraparp Rd, Khon Kaen 40002, Thailand
关键词
penile cancer; PD-L1; programmed death-ligand 1; squamous cell carcinoma of penis; PD-L1; EXPRESSION;
D O I
10.3892/br.2023.1627
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The present study aimed to demonstrate the proportion of the programmed death-ligand 1 (PD-L1) expression in penile cancer patients and the association with clinicopathological parameters. Formalin-fixed paraffin-embedded specimens were obtained from 43 patients with primary penile squamous cell carcinoma treated at Srinagarind Hospital, Faculty of Medicine, Khon Kaen University, between 2008 and 2018. PD-L1 expression was evaluated by the immunohistochemistry using an SP263 monoclonal antibody. PD-L1 positivity was defined as >25% tumor cell staining or >25% tumor-associated immune cell staining. The correlation between PD-L1 expression and clinicopathological parameters was analyzed. A total of eight of 43 patients (18.6%) were identified as positive for PD-L1 expression in tumor cells and tumor-infiltrating lymphocytes. In the PD-L1 positive group, there was a significant association with pathological T stage (P=0.014) with a higher percentage of PD-L1 positive tumors in T1 stage compared with T2-T4 stage. In this cohort, there was a trend towards longer survival in patients with positive PD-L1 expression (5-year OS: 75% vs. 61.2%, P=0.19). Lymph node involvement and the location of tumor at the shaft of penis were two independent prognostic factors for survival. In conclusion, the PD-L1 expression was detected in 18% of penile cancer patients and high expression of PD-L1 was associated with the early T stage.
引用
收藏
页数:8
相关论文
共 50 条
[21]   Multicentric analytical comparability study of programmed death-ligand 1 expression on tumor-infiltrating immune cells and tumor cells in urothelial bladder cancer using four clinically developed immunohistochemistry assays [J].
Kristina Schwamborn ;
Johannes U Ammann ;
Ruth Knüchel ;
Arndt Hartmann ;
Gustavo Baretton ;
Felix Lasitschka ;
Peter Schirmacher ;
Till Braunschweig ;
Robert Tauber ;
Franziska Erlmeier ;
Stefanie Hieke-Schulz ;
Wilko Weichert .
Virchows Archiv, 2019, 475 :599-608
[22]   Programmed Death-Ligand 1 Expression in Lymphovascular Tumor Emboli in Lung Cancer [J].
Yeh, Yi-Chen ;
Ma, Hsiu-Hsun ;
Chu, Ping-Yuan ;
Ho, Hsiang-Ling ;
Chou, Teh-Ying .
JTO CLINICAL AND RESEARCH REPORTS, 2022, 3 (07)
[23]   Infiltration of tumor-associated macrophages is involved in tumor programmed death-ligand 1 expression in early lung adenocarcinoma [J].
Shima, Toshiyuki ;
Shimoda, Masayuki ;
Shigenobu, Takao ;
Ohtsuka, Takashi ;
Nishimura, Tomoyasu ;
Emoto, Katsura ;
Hayashi, Yuichiro ;
Iwasaki, Tatsuro ;
Abe, Takayuki ;
Asamura, Hisao ;
Kanai, Yae .
CANCER SCIENCE, 2020, 111 (02) :727-738
[24]   The role of programmed death ligand-1 and tumor-infiltrating lymphocytes in breast cancer overexpressing HER2 gene [J].
Li, Yanchun ;
Opyrchal, Mateusz ;
Yao, Song ;
Peng, Xuan ;
Yan, Li ;
Jabbour, Hossam ;
Khoury, Thaer .
BREAST CANCER RESEARCH AND TREATMENT, 2018, 170 (02) :293-302
[25]   Clinical relevance and significance of programmed death-ligand I expression, tumor-infiltrating lymphocytes, and p16 status in sinonasal squamous cell carcinoma [J].
Quan, Huatao ;
Yan, Li ;
Wang, Shuyi ;
Wang, Shengzi .
CANCER MANAGEMENT AND RESEARCH, 2019, 11 :4335-4345
[26]   Programmed death ligand 1 and tumor-infiltrating CD8+ T lymphocytes are associated with the clinical features in meningioma [J].
Yaochuan Zhang ;
Xiaoliang Wang ;
Mengwu Shi ;
Yifu Song ;
Juanhan Yu ;
Sheng Han .
BMC Cancer, 22
[27]   Programmed death ligand 1 (PD-L1) in colon cancer and its interaction with budding and tumor-infiltrating lymphocytes (TILs) as tumor-host antagonists [J].
Lang-Schwarz, Corinna ;
Melcher, Balint ;
Hartmann, Arndt ;
Bertz, Simone ;
Dregelies, Theresa ;
Lang-Schwarz, Klaus ;
Vieth, Michael ;
Sterlacci, William .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2021, 36 (11) :2497-2510
[28]   Salmonella Breaks Tumor Immune Tolerance by Downregulating Tumor Programmed Death-Ligand 1 Expression [J].
Chen, Man-Chin ;
Pangilinan, Christian Ronquillo ;
Lee, Che-Hsin .
CANCERS, 2020, 12 (01)
[29]   Programmed Death-Ligand 1 as a Regulator of Tumor Progression and Metastasis [J].
Vathiotis, Ioannis A. ;
Gomatou, Georgia ;
Stravopodis, Dimitrios J. ;
Syrigos, Nikolaos .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (10)
[30]   The expression of BHLHE22 in endometrial carcinoma: Associations with mismatch repair protein expression status, tumor-infiltrating immune cells, programmed death-ligand 1 and clinical outcomes [J].
Chen, Lin-Yu ;
Chen, Hsing-Yu ;
Lai, Hung-Cheng ;
Lin, Shiou-Fu ;
Wen, Kuo-Chang ;
Darmawi ;
Liew, Phui-Ly .
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2025, 64 (01) :110-119